Capital Fund Management (CFM)’s Array Biopharma Inc ARRY Stock Holding History

Capital Fund Management (CFM)’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,133	Closed	-$655K	–	2007
2019 Q2	$655K	Buy	14,133 +1,248	+10%	+$35K	0.01%	1136
2019 Q1	$314K	Buy	+12,885	New	+$268K	﹤0.01%	1433
2018 Q4	–	Sell	-16,162	Closed	-$246K	–	2363
2018 Q3	$246K	Sell	16,162 -44,537	-73%	-$682K	﹤0.01%	1833
2018 Q2	$1.02M	Buy	+60,699	New	+$966K	0.01%	1330

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Capital Fund Management (CFM)'s ARRY Position: Q3 2019 in Review

Capital Fund Management (CFM) sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 14,133 shares — an estimated $655K sold.

Capital Fund Management (CFM) first reported a position in ARRY in Q2 2018 and held it in 4 quarters. The position peaked at $1.02M in Q2 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Capital Fund Management (CFM) reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Capital Fund Management (CFM) sold 14,133 Array Biopharma Inc shares in Q3 2019, an estimated $655K.
Capital Fund Management (CFM) first reported a position in Array Biopharma Inc in Q2 2018 and held it in 4 quarters.
Capital Fund Management (CFM)'s Array Biopharma Inc position peaked at $1.02M in Q2 2018.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2019, filed 13 Nov 2019.